Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice.
about
Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatmentRole of Inflammation in Muscle Homeostasis and MyogenesisThe TWEAK-Fn14 pathway: a potent regulator of skeletal muscle biology in health and diseaseCellular and molecular mechanisms of muscle atrophyMolecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?Understanding cachexia as a cancer metabolism syndromeProteotoxicity: an underappreciated pathology in cardiac diseaseCancer cachexia: impact, mechanisms and emerging treatmentsReversal of muscle atrophy by Zhimu-Huangbai herb-pair via Akt/mTOR/FoxO3 signal pathway in streptozotocin-induced diabetic miceRegulatory circuitry of TWEAK-Fn14 system and PGC-1α in skeletal muscle atrophy program.Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved.Bovine milk-derived exosomes for drug delivery.The PERK arm of the unfolded protein response regulates satellite cell-mediated skeletal muscle regenerationThe TWEAK-Fn14 dyad is involved in age-associated pathological changes in skeletal muscleAn ethanolic extract of Artemisia dracunculus L. regulates gene expression of ubiquitin-proteasome system enzymes in skeletal muscle: potential role in the treatment of sarcopenic obesity.DNA methyltransferase 3a and mitogen-activated protein kinase signaling regulate the expression of fibroblast growth factor-inducible 14 (Fn14) during denervation-induced skeletal muscle atrophy.Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1TRAF6 promotes myogenic differentiation via the TAK1/p38 mitogen-activated protein kinase and Akt pathways.Delayed recovery of skeletal muscle mass following hindlimb immobilization in mTOR heterozygous mice.Muscle wasting and cachexia in heart failure: mechanisms and therapies.Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx miceTRAF6 coordinates the activation of autophagy and ubiquitin-proteasome systems in atrophying skeletal muscle.Cancer cachexia update in head and neck cancer: Pathophysiology and treatment.Swimming-induced exercise promotes hypertrophy and vascularization of fast skeletal muscle fibres and activation of myogenic and angiogenic transcriptional programs in adult zebrafish.The effects of an ActRIIb receptor Fc fusion protein ligand trap in juvenile simian immunodeficiency virus-infected rhesus macaques.Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis.The TWEAK-Fn14 system: breaking the silence of cytokine-induced skeletal muscle wasting.Myosin heavy chain is not selectively decreased in murine cancer cachexiaIncreased serum tumor necrosis factor receptor-associated factor-6 expression in patients with non-metastatic triple-negative breast cancer.MyD88 regulates physical inactivity-induced skeletal muscle inflammation, ceramide biosynthesis signaling, and glucose intolerance.The E3 ubiquitin ligase TRAF6 intercedes in starvation-induced skeletal muscle atrophy through multiple mechanismsSarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass.TWEAK and TRAF6 regulate skeletal muscle atrophy.Akt (protein kinase B) isoform phosphorylation and signaling downstream of mTOR (mammalian target of rapamycin) in denervated atrophic and hypertrophic mouse skeletal muscleConsilience in sarcopenia of cirrhosis.Expression of TRAF6 and ubiquitin mRNA in skeletal muscle of gastric cancer patients.The AMPK-related kinase SNARK regulates muscle mass and myocyte survival.Effect of Electroacupuncture on the Expression of Glycyl-tRNA Synthetase and Ultrastructure Changes in Atrophied Rat Peroneus Longus Muscle Induced by Sciatic Nerve Injection InjuryTRAF molecules in cell signaling and in human diseasesTWEAK promotes exercise intolerance by decreasing skeletal muscle oxidative phosphorylation capacity.
P2860
Q26775254-22388A02-B61D-4E9C-8425-CA385414871AQ26778322-25679033-CB39-4E15-BED6-4F2D53D0D6E2Q26999255-731A4EE8-5AD5-49A9-B9D0-701226F2C43AQ27012762-B97A43DF-88B1-479C-8E3A-BDE00A46AD4FQ28068034-DA6DD0AA-FF85-4371-A481-4875EE57B070Q28069390-2C6AAF67-AA6A-4715-A2CC-6662FEECB9DDQ28304890-239D5D3B-AACB-4CBA-8287-0B4300DB4828Q28384479-E5A3C879-A544-42E8-8303-B599C00F3F1EQ28540078-ECBC1E6B-1FC2-4B06-85C0-F255F09D08E1Q28658848-C10A5D19-03AE-456A-97B1-D2AA2AF919BCQ30384810-2C6A4077-8112-4469-82F2-15972360DB7EQ30696706-08D4D126-F053-4AFB-A0DE-E685C4A898E2Q33563452-044AEB27-8BD4-4314-B91A-23221202AB87Q33724956-6CD72766-2780-49C3-8DDC-68B00C6FFD3AQ33849584-4C99D1A2-7AA3-446C-8C54-E2980C24F8BCQ33931130-BC15F3D2-A303-4151-B882-9DD490F4BDA2Q34200869-98BC2B45-C949-4439-AD45-EC69DB7154B5Q34229995-33FF4CB8-1C4F-42AB-8F79-EF558FAA35C0Q34321178-4A35A57F-992C-43E1-82BE-D86BC52C9396Q34681621-B9919DDB-E102-4BEF-8595-EDC2F776944CQ34973330-F81E4687-2FD4-42C6-AE7A-3AC7C4CC8BD0Q35079491-B60A323B-398C-4CE0-A9F6-1A03EFA284BAQ35122201-1C389312-7CCF-47D5-B13C-2966318D17D8Q35228265-15464A45-4847-4D8D-86B6-E6FF1ACC9567Q35410626-470C8C71-C6A8-4D53-ACB9-7B63CCB976E3Q35669093-9399B6F1-54E3-4FD9-AD18-9994D69C51C1Q35671234-571946DF-4211-409B-999E-E67F34045EA9Q35705679-9DD4661C-348E-4FD3-A505-C8BA0828971BQ35759017-967E6D15-2CF1-46D7-ACF0-7CF7996DDA87Q35813366-5F9B1849-068F-48D0-9FE0-7CE23D679FF0Q35826684-5AEC0856-EBA7-4478-A529-F4D50CD76834Q36028202-D31FE70C-A994-4A68-A1E3-4AEC1B2A9173Q36097846-9976FDCF-CC3C-4738-BBEE-BF287D6AEFDDQ36123187-2A612DE2-9156-43FB-B25B-F559C9A0E602Q36421047-19BB45BF-A4F4-40C5-B58E-CA06F6037B09Q36468812-1C1C73C0-2F04-4A47-98FF-F6D3A28435A2Q36515098-8F5D3183-CBC9-447F-BECE-999C6E61D250Q36909944-873DB6F8-9A2B-4A25-81A3-59D791791A2EQ36972287-01EF40A5-A119-4F02-A5F8-F968BE6F337AQ37014194-F276C9D0-904B-4FFF-8285-BA5400A45379
P2860
Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice.
@ast
Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice.
@en
Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice.
@nl
type
label
Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice.
@ast
Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice.
@en
Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice.
@nl
prefLabel
Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice.
@ast
Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice.
@en
Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice.
@nl
P2093
P2860
P356
P1476
Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice
@en
P2093
Bryant G Darnay
Pradyut K Paul
Sanjay K Gupta
Shephali Bhatnagar
Siva K Panguluri
Yongwon Choi
P2860
P304
P356
10.1083/JCB.201006098
P407
P50
P577
2010-12-01T00:00:00Z